MedPath

Effect of coenzyme Q10 supplement to decrease cardiac complications in ß-Thalassemia major patients

Phase 3
Recruiting
Conditions
D56.1
Beta Thalassemia major.
Beta thalassemia
Registration Number
IRCT20221211056777N4
Lead Sponsor
Shahre-kord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Beta Thalassemia major
Informed consent to participate in the intervention
No history of underlying disease
Not to use other supplements

Exclusion Criteria

Pregnancy or breastfeeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.